Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Obes Surg ; 34(6): 2033-2041, 2024 Jun.
Artículo en Inglés | MEDLINE | ID: mdl-38653887

RESUMEN

PURPOSE: Postoperative changes in gut microbiota may occur in patients undergoing Roux-en-Y gastric bypass surgery. In this study, we evaluate the impact of administering probiotic tablets on the gastrointestinal function and metabolic status of these patients. MATERIALS AND METHODS: This double-blinded randomized clinical trial was conducted from 2021 to 2022 on 135 Roux-en-Y surgery candidates. The intervention group underwent the surgical procedure and started receiving probiotic supplements (Familact Co.) 1 week after surgery; the control group received a placebo. The laboratory and anthropometric data were measured and analyzed before and 3 and 6 months after the intervention. GIQLI questionnaire was also used at the beginning and 6 months after the intervention to evaluate GI symptoms. RESULTS: We observed significantly reduced BMI in both groups after surgeries (P < 0.001). The levels of FBS and HbA1C were significantly lower in the probiotic group compared to the placebo in 3 months (P = 0.02 and P = 0.001, respectively) and 6 months (P < 0.001 for both) after the intervention. The levels of vitamin B12 increased significantly in the probiotic group (P < 0.001), and the values were substantially higher than the placebo group in 3 and 6 months (P < 0.001), respectively. Analysis of the GIQLI questionnaire before and 6 months after interventions also revealed significant improvement in the GIQLI score in both groups (P < 0.001 for probiotics and P = 0.03 for placebo). CONCLUSION: Probiotic supplement administration following RYGB improves patients' vitamin and metabolic profile, as well as GI function, although it cannot significantly affect weight loss.


Asunto(s)
Derivación Gástrica , Obesidad Mórbida , Probióticos , Humanos , Método Doble Ciego , Probióticos/uso terapéutico , Probióticos/administración & dosificación , Femenino , Masculino , Adulto , Obesidad Mórbida/cirugía , Persona de Mediana Edad , Microbioma Gastrointestinal/efectos de los fármacos , Pérdida de Peso , Índice de Masa Corporal , Calidad de Vida , Resultado del Tratamiento , Suplementos Dietéticos
2.
Eur J Obstet Gynecol Reprod Biol ; 246: 113-116, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-32004879

RESUMEN

OBJECTIVE: Peritoneal adhesions may develop after every abdominopelvic surgery. Many agents and technical modifications have been investigated to minimize adhesions. Punica granatum (pomegranate) flower has some anti-inflammatory and antioxidative effects that would reduce the formation of peritoneal adhesions. In the present study, the effects of different doses of oral Punica granatum flower extract on postoperative peritoneal adhesions were evaluated in a rat model. STUDY DESIGN: Thirty-two female Wistar rats were divided into four groups: one control group (CG) and three experimental groups, treated with 100 (EG100), 200 (EG200), and 400 (EG400) mg/kg/day Punica granatum extract orally for eight days. Induction of peritoneal adhesions was done in all groups using the same method. Two weeks after the first surgery, all rats re-operated and adhesions were evaluated via both macroscopic and microscopic changes. RESULTS: We observed that rats in the control group had statistically higher adhesion area and more severe adhesions when compared to all experimental groups. Besides, those in the EG-400 group had a significantly lower rate of foreign body reaction in serosal layer when compared to the other three study groups. Other microscopic findings were comparable between the four groups. CONCLUSION: Administration of the oral Punica granatum flower extract was associated with a decreased quantity and quality of the adhesions in the animal model of rat in this study. This therapy might be an effective and safe strategy to reduce intraperitoneal adhesion after abdominal surgeries in animal models.


Asunto(s)
Flores , Enfermedades Peritoneales/prevención & control , Peritoneo/efectos de los fármacos , Fitoterapia , Extractos Vegetales/farmacología , Granada (Fruta) , Adherencias Tisulares/prevención & control , Administración Oral , Animales , Femenino , Fibrosis , Reacción a Cuerpo Extraño/patología , Linfocitos/patología , Macrófagos/patología , Neutrófilos/patología , Enfermedades Peritoneales/patología , Peritoneo/patología , Peritoneo/cirugía , Células Plasmáticas/patología , Ratas , Adherencias Tisulares/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA